ABSTRACT One of the difficulties associated with commercial layer production is the development of osteoporosis in hens late in the production cycle. In light of this fact and because of hens' unique requirements for Ca, many studies have focused on the regulation of Ca and the role of estrogen in this process. The time course of estrogen synthesis over the productive life of hens has been well documented; increased circulating estrogen accompanies the onset of sexual maturity while decreases signal a decline in egg production prior to a molt. Numbers of estrogen receptors decrease with age in numerous tissues. The parallel changes in calcium-regulating proteins, primarily Calbindin D28K, and in the ability of duodenal cells to transport Ca, are thought to occur as a result of the changes in estrogen, and are also reversible by the molt process. In addition to the traditional model
INTRODUCTION
Bone is an exceedingly complex tissue with multisystem regulation. It serves as structural support and also as a reservoir for minerals-for the purposes of this review, primarily Ca. Bone is particularly intriguing in the laying hen because of the phenomenal demands for Ca for eggshell and because of the occurrence of medullary bone, an extremely labile bone that develops within specific bones of female birds (Miller, 1992) at the onset of sexual maturity (Simkiss, 1967) . Although the development of medullary bone requires estrogen and androgens (e.g., Common et al., 1948; Simkiss, 1967) , of the 2, estrogen is more intimately involved in Ca homeostatic mechanisms and is also implicated in the later development of osteoporosis. The following discussion outlines the roles of estrogen in both of these aspects of bone physiology in the hen. To whom correspondence should be addressed: mbeck1@unl.edu.
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of estrogen action, evidence now exists for a possible nongenomic action of estrogen via membrane-bound receptors, demonstrated by extremely rapid surges of ionized Ca in chicken granulosa cells in response to 17β-estradiol. Estrogen receptors have also been discovered in duodenal tissue, and tamoxifen, which binds to the estrogen receptor, has been shown to cause a rapid increase in Ca transport in the duodenum. In addition, recent evidence also suggests that mineralization of bone per se may not explain entirely the etiology of osteoporosis in the hen but that changes in the collagen matrix may contribute through decreases in bone elasticity. Taken together, these studies suggest that changes in estrogen synthesis and estrogen receptor populations may underlie the age-related changes in avian bone. As with postmenopausal women, dietary Ca and vitamin D are of limited benefit as remedies for osteoporosis in the hen.
Estrogen and Ca Regulation
Calcium homeostasis in the hen, as in other female animals, is regulated directly and indirectly in a number of tissues, primarily gut, kidney, and bone (Etches, 1987) . The hormones with the greatest involvement in Ca regulation in the bird are parathyroid hormone (PTH), 1,25-dihydroxycholecalciferol (1,25D 3 ), and 17β-estradiol, with calcitonin playing a minor role if any. Briefly, and without implying a hierarchical relationship, the action of each hormone is as follows:
Calcium is regulated indirectly at the gut and at the kidney. In duodenal tissue, absorption from the lumen is controlled primarily by 1,25D 3 , the active form of vitamin D converted from 25-hydroxycholecalciferol (25D 3 ) by the enzyme 25(OH) 2 -1-α-hydroxylase in the kidney (Kenney, 1976; Soares, 1984) , increasing 1,25D 3 in intestinal mucosa (Castillo et al., 1979) . This activated hormone, in turn, regulates the transcription of calbindin D28K (CaBP-28K) (Bar and Hurwitz, 1987) , as evidenced by mRNA expression (Emtage et al., 1973; Bar et al., 1992) , that is independently and posttranscriptionally modulated by dietary Ca (Theofan et al., 1987) . Estrogen (in vitamin D 3 -replete birds and in concert with normal low levels of testosterone (Castillo et al., 1979) exerts its influence at several points. It is required for activation of the 25(OH) 2 -1-α-hydroxylase and thus the activation of vitamin D 3 (Tanaka et al., 1978) . It up-regulates gut mucosal 1,25D 3 receptors in the chicken (Wu et al., 1994) and in the rat (Schwartz et al., 2000) , and it is required, with 1,25D 3 , for synthesis of CaBP-D28K in gut mucosa (Nys et al., 1992) . The estrogen receptors involved in the gut responses noted above are intracellular or nuclear, or both, and thus function at a transcriptional or genomic level (Welshons et al., 1984; Schwartz et al., 2000) .
Although entry of Ca into the body is through the gut, and local factors (1,25D 3 receptors, estrogen receptors, CaBP-D28K, etc.) are essential control elements (Hurwitz, 1989) , the master regulator of Ca homeostasis is the kidney, where regulation is indirect and direct-and estrogen is required in both cases. As noted above, estrogen increases Ca uptake in the gut by activating 25(OH) 2 -1-α-hydroxylase (Tanaka et al., 1978) in the kidney. There, estrogen first up-regulates PTH receptors, making PTH accessible to PTH-dependent adenylate cyclase necessary for the activation of the 25(OH) 2 -1-α-hydroxylase (Forte et al., 1983) . There is also, however, a direct effect of estrogen in the kidney on Ca homeostasis. Reabsorption of Ca in the tubules of the avian kidney has been well studied with regard to PTH (Clark et al., 1976; Elaroussi et al., 1993) . Normally, 98% of the Ca filtered in the kidney is reabsorbed in the tubule. In human females, excretion of Ca increases in estrogen deficiency and estrogen therapy increases the efficiency of reabsorption (Notelovitz, 1997) . It is not clear how estrogen exerts this effect, but it is presumably through its effect on PTH via the receptor up-regulation mentioned. In the avian kidney, estrogen increases kidney responsiveness to PTH (Elaroussi et al., 1993) . In elderly female human subjects, estrogens have been shown to increase the sensitivity of the renal response to exogenous PTH administration (Imanaka et al., 1988) , and 17β-estradiol has been shown to increase renal expression of PTH-related peptide mRNA, which suggests that the pharmacological effect of estrogen preventing the postmenopausal leak of Ca through the kidney is via up-regulation of this gene (Cros et al., 1998) .
Bone is another site where Ca is regulated directly. It has been well established that healthy bone is maintained through a balance between osteoclastic and osteoblastic activities, both of which involve estrogen. As a vast oversimplification, knowing that bone physiology is covered in other papers in this symposium, osteoclasts provide Ca by mobilizing it from bone, and osteoblasts turn Ca into bone (e.g., Loveridge et al., 1992) . Regulated by systemic and local factors (Price and Russell, 1992) , bone formation (Ali, 1992) and remodeling is exceedingly complex. Estrogen is an important factor in growth and maturation of bone and also in adult bone turnover. Estrogen deficiency enhances bone resorption through a decrease in its antiresorptive effect on osteoclasts (Vaananen and Harkonen, 1996; Notelovitz, 1997) , and in older adult women, estrogen deficiency induces osteoclastic resorption of cancellous and cortical bone (Vaananen and Harkonen, 1996) . The effect of estrogen on osteoclasts is presumed to be directly through its interaction with estrogen receptors (Oursler et al., 1991) . Because estrogen up-regulates its own receptor in various tissues and species (Dix and Jordan, 1980; Varriale and Tata, 1990; Bergman et al., 1992; Wu et al., 1996; Ing and Tornese, 1997; Prins and Birch, 1997; Ing and Ott, 1999) , deficiency of estrogen would result in a down-regulation of the receptor population and thus decrease the antiresorptive effect of estrogen. In addition, estrogen has been shown to prevent osteocyte apoptosis in the rat, thus directly or indirectly regulating the set point between bone resorption and formation (Tomkinson et al., 1998) . It has been shown that osteoclast formation from osteocytes is PTH dependent and that estrogen blocks a protein kinase pathway and thereby inhibits PTH-stimulated osteoclast formation (Kanatani et al., 1998) .
On the other side of the bone equation is the osteoblast and its bone-forming function. The effect of estrogen on this process is less clear than it is on the osteoclast. Its role is largely thought to be stimulatory, mediating bone matrix synthesis and coordinating and stimulating remodeling of bone (reviews: Ali, 1992; Price and Russell, 1992) . It is unknown whether the effects on estrogen are direct or are mediated through coupling mechanisms between bone resorption and formation (Vaananen and Harkonen, 1996) . Estrogen receptors, however, have been found on osteoblasts in humans (Eriksen et al., 1988) and in medullary osteoblasts in hens (Ohashi et al., 1990) . Relatively high estrogen levels administered to postmenopausal women appear to stimulate osteoblast activity (Tobias and Compston, 1999) .
There is recent evidence for a direct regulation of Ca at the gut in addition to the better-known vitamin D 3 -associated mechanism. The action of steroid hormones has traditionally been thought to occur solely through either intracellular receptors transported to the nucleus or nuclear receptors per se (Welshons et al., 1984; Schwartz, 2000) . Effects of steroid binding to such receptors are observed after a latency of several hours and may last for days-a phenomenon known as the genomic phase of hormone regulation (Harvey et al., 2002) . As discussed and demonstrated in chicken granulosa cells by Morley et al. (1992) , the long-latency genomic actions of steroid hormones is not sufficient to explain all steroid actions. Indeed, some 50 yr ago, Hans Ussing described the mechanism by which ions are transported across skin (Harvey et al., 2002) . Such nongenomic mechanisms of steroid hormones that involve Ca have been shown to exist in rat intestine and rabbit kidney, in both cases stimulated by 17β-estradiol (Colin et al., 1999; Han et al., 2000) . Estrogen receptor-α (ERα) has recently been discovered in avian duodenum. The amount of ERα decreases with age in the hen and responds to tamoxifen with increased in vitro Ca transport (Franzen et al., 2002; Hansen et al., 2003) . Although not tested specifically as a candidate for nongenomic action of estrogen on the avian duodenum, it is likely that this mechanism is operational in birds as in mammals. If so, the presence in avian duodenum of estrogen receptors could explain in part the rapidly changing fluxes in Ca uptake by the gut during different phases of the ovulatory cycle.
Osteoporosis
Imbalances between osteoblast and osteoclast activity result in disturbances of bone integrity, with the severity characterized by the amount of bone mass remaining relative to peak. Osteopenia, or bone loss, is generally considered to have occurred at 1 to 2.5 SD below peak bone mass and osteoporosis (one type of osteopenia; Randall and Duff, 1988) by ≥2.5 SD below peak bone mass (Notelovitz, 1997) . In humans, 2 primary types are recognized, excluding those from secondary causes, such as hyperparathyroidism. Type I occurs in postmenopausal women; type II is age-related and occurs in both men and women over 70 yr of age (Tolstoi and Levin, 1992) . Type I osteoporosis, associated with declining estrogen postmenopausally, is characterized by an accelerated resorption of bone for about 10 yr followed by a slower steady loss (Riggs et al., 1998) . The resulting pathophysiology, caused by increased bone sensitivity to PTH, is increased mobilization of ionized Ca, which in turn leads to decreased circulating PTH, decreased 1,25D3 synthesis, and decreased Ca absorption from the gut (Tolstoi and Levin, 1992) . In contrast, in elderly men and in elderly women but unrelated to menopause, Type II osteoporosis does not result from accelerated bone resorption. Instead, there is general impairment of renal synthesis of 1,25D 3 resulting in decreased activity of 25(OH)-1-hydroxylase in kidney and a secondary hyperparathyroidism. This may be accompanied by a defect in osteoblast function, such that new bone is not formed (Tolstoi and Levin, 1992) . Characteristics of osteoporosis are low-energy fractures and abnormal microarchitecture (Lane et al., 2003) . Because osteoporosis is easier to prevent than to treat (Body, 2002) , building bone mass prior to declines in estrogen and maintaining load-bearing exercise is recommended in addition to dietary Ca and vitamin D (Lane et al., 2003) . Pharmacologic treatment of Type I osteoporosis is exceedingly difficult, in part because estrogen receptor physiology is not straightforward [Davison and Davis (2003) have termed estrogen receptors "promiscuous"] but includes antiosteoporotic agents that inhibit osteoclast activity (estrogen supplementation), bisphosphonates (often toxic to the GI tract), estrogen antagonists (for selective estrogen receptor modulation), and bone-formation agents (fluorides, anabolic androgens, PTH, ipriflavone) (Cotrozzi and Relli, 1994; Body, 2002; Davison and Davis, 2003; Lane et al., 2003) . Type II osteoporosis is treated with agents designed to stimulate osteoblast activity (Tolstoi and Levin, 1992) , although low estrogen has also been associated with this form of osteoporosis in women and men, which suggests that similar treatments might be of benefit (Riggs et al., 1998; Khosla et al., 2001 ). 
Hens and Estrogen
As hens mature sexually, estrogen concentrations in plasma gradually increase, with more marked increases occurring from 16 to 20 wk of age (Johnson and van Tienhoven, 1980; Whitehead and Fleming, 2000; Madison et al., 2002) . Concentrations remain high for the next several weeks with daily surges occurring approximately 4 to 6 h prior to ovulation and coincident with the daily surges of luteinizing hormone (LH) and progesterone (Johnson and van Tienhoven, 1980; Etches and Cheng, 1981) . The exact time course of the secretion pattern of estrogen after hens reach peak production is not clear; few studies have monitored plasma estrogen systematically over the entire production period, and those that have done so have not taken samples often enough to give a clear picture. It is generally accepted that estrogen declines over the production year (Johnson, 1986) , drops very low during molt (Hoshino et al., 1988) , and increases again as hens are brought back into production (Johnson, 1986; Etches, 1987) . These changes underlie the egg production patterns of commercial layers, in which there is a gradual decline in egg numbers from the peak reached shortly after sexual maturity. When commercial layers drop below ∼80% production, 3 molt regimens are initiated that take hens out of production from ∼68 to 72 wk of age. This induces a rest of the reproductive system and a return to reproductive condition for a second laying cycle.
In a recent study conducted to establish more definitively estrogen-Ca relational changes over time in the hen, Hansen et al. (2003) confirmed the dramatic decrease in estrogen in hens at 70 wk compared to those in peak production (∼29 wk). This study also documented parallel changes in estrogen receptor populations in both kidney and duodenum. As shown by immunochemistry staining and Western blot analysis, ERα decreased with age in hens (Hansen et al., 2003) ; Ca absorption by duodenal tissue also decreased linearly from prelay highs, which agrees with earlier work on Ca absorption and CaBP-D28K concentrations (Berry and Brake, 1991; Al-Batshan et al., 1994) .
Hens and Osteoporosis
First described by Couch (1955) , cage layer fatigue has since been classified as an extreme manifestation of the osteoporosis that develops in laying hens kept in cages and that is associated with bone loss and fractures. From an extensive review of the literature, several things appear to be generally accepted with regard to bone in laying hens: structural bone loss begins to occur at onset of lay with the appearance of medullary bone, considered non-or only slightly structural in nature; bone loss is exacerbated by cages, although aviary housing is not sufficient to prevent or reverse bone fragility; between hens and within flocks, the percentage of broken bones observed is highly variable as is the incidence of fracture in various bones; bone issues of caged layers are not strictly nutritional in nature, although Ca and vitamin D in the diet are essential, and particulate Ca spares structural bone by its enhanced availability for medullary formation; there is clearly a genetic component; and it is clearly a welfare issue (Bell and Siller, 1962; Wilson et al., 1992; Wilson and Hughes, 1993; Fleming et al., 1994 Fleming et al., , 1996 Fleming et al., , 1998 Rennie et al., 1997; AzizAbdul, 1998; Knowles and Wilkins, 1998; Newberry et al., 1999; Bishop et al., 2000; Whitehead and Fleming, 2000; Cransberg et al., 2001; Keshavarz, 2001; Spark et al., 2002) .
Earlier observations and studies with end of lay hens suggested that bones become depleted of mineral (Peterson, 1965) , in part at least from an increasing inability of the liver to hydroxylate dietary vitamin D 3 to 25D 3 (Soares et al., 1976) . Frost et al. (1990) concluded that vitamin D 3 could provide enough 1,25D 3 through hydroxylation to sustain production and shell quality but not tibia weight or strength in old hens. Al-Batshan et al. (1994) found that bones ashed for mineral content had less mineral at end of lay compared to those at sexual maturity. These findings fit well with breaking-strength studies, with field observations that bones of end of lay hens are brittle and break easily; and with findings that supplementing the diet with Ca or vitamin D or both improved bone breaking strength (Soares et al., 1988; Frost and Roland, 1991) , although Bell and Siller (1962) suggested that an exogenous Ca deficiency did not appear to be involved. More recent studies, however, through the use of x-ray densitometry and histomorphometric analysis, indicate that mineral content in bones of old hens actually increases although they do become brittle (Fleming et al., 1994 (Fleming et al., ,1996 Whitehead and Fleming, 2000; Hester et al., 2002; Hansen et al., 2003) . It has become apparent that repartitioning occurs in certain bones over time, with overall increases in medullary bone and decreases in structural bone . The net increase in mineral content with the lack of formation of structural bone has led to the suggestion that the osteoclast-osteoblast coupling that occurs in normal bone does not function in osteoporotic bone in the hen . In contrast, Newbrey et al. (1992) found that enhancing the diet with vitamin D resulted in increased medullary bone formation with decreased cortical bone resorption in aged hens and interpreted their results as indicative of such coupling. Medullary bone is thought to be more easily accessed by osteoclasts and more easily formed by osteoblasts because it is highly labile and far less structured than trabecular or cortical bone (Hurwitz 1965) . Similarly, in postmenopausal women, remodeling of bone also involves primarily trabecular bone rather than cortical bone, with a net loss of cortical volume, because of a higher surface-to-volume ratio of trabecular bone (Marcus, 1987) . Although not inherently structural, medullary bone has been shown to contribute to overall bone strength (Fleming et al., 1998) , and brittleness appears to be a function of changes in the collagen matrix rather than loss of bone (Knott et al., 1995; Rath et al., 2000) . Indeed, mineral percentage increases, and collagen percentage decreases in osteoporotic bone, resulting in an increased ratio of mineral to collagen, and changes in the biochemical properties occur (Knott et al., 1995) Avian Osteoporosis and EstrogenAre They Linked?
This question is interesting and not entirely straightforward. Because high estrogen at point of lay induces the formation of medullary bone at the expense of structural bone, it has been suggested that estrogen initiates osteoporosis at that time . In addition, at end of lay, the hen's ovary is still functioning (in contrast to those of postmenopausal women)-egg production continues, with estrogen concentrations sufficient to sustain it, even though both are reduced compared with early lay. Not all hens or flocks become clinically osteoporotic, either at all or at the same age (E. Wallner-Pendleton, 2003, Pennslyvania State University, State College, PA, personal communication), and as noted earlier, housing, nutrition, and genetics are all factors that affect expression and onset of the condition. In addition, different bones exhibit signs of osteoporosis at different times relative to onset of lay. Certainly the occurrence of medullary bone confuses the issue.
From a mechanistic perspective, however, reductions in estrogen synthesis and secretion over time do occur and would logically result in all of the following: diminished activity of 25(OH) 2 -1-α-hydroxylase in the kidney (Elaroussi et al., 1993) , decreased availability of 1,25(OH) 2 D 3 for stimulation of Ca transport (Navickis et al., 1979) , increased sensitivity of bone to PTH-stimulated osteoclastic activity (Etches, 1987) , decreased CaBP-D28K in gut tissue and therefore less Ca available from the diet (Berry and Brake, 1991; Al-Batshan et al., 1994; Bar et al., 1996) , and net resorption rather than accretion of structural bone (Fleming et al., 1996; Rennie et al., 1997) . Each piece of this cascade appears to be in place in the hen. It is difficult to imagine that down-regulation of estrogen receptors with diminished circulating estrogen (Varriale and Tata, 1990; Bergman et al., 1992; Wu et al., 1996; Prins and Birch, 1997) would not occur in the hen, although this has not been directly reported.
Estrogen is the initiating factor in the cascade of events that leads to Ca homeostasis; it is antiresorptive (i.e., inhibits resorption by osteoclasts) and stimulates bone formation (Ali, 1992) . A decrease of estrogen reduces the inhibitory effect on osteoclasts and the stimulatory effect on osteoblasts, leading to a net loss of bone. Whether, in the hen, the net loss of cortical bone with the net increase in total bone is the same as net loss of cortical bone in mammalian females with low estrogen must be questioned. To the extent that the same osteoporosis combating agents typically used in humans also have been shown to be efficacious (although not necessarily practical) in birds (Thorp et al., 1993; Wilson and Solomon, 1998; Whitehead and Fleming, 2000) , it appears that avian osteoporosis mimics to some extent type I human osteoporosis. Certainly the mechanistic factors are very indicative of that. It is possible that a reexamination of the defined use of the word, "osteoporosis," to characterize the avian disease needs to occur and that cage layer fatigue (not necessarily accompanied by paralysis) may in fact be more accurate. Hens at the end of lay are taken out of reproductive condition artificially and do not go naturally through seasonal breeding cycles. In addition, dietary Ca is available more consistently to the caged laying hen-a situation that is very unlike that experienced by wild birds, including other fowl species.
In wild avian species, molt is not primarily associated with cessation of lay-at least not causally. Replacement of feathers on a regular basis as a condition for migration is achieved by molt resulting from extended periods of anorexia (Mrosovsky and Sherry, 1980) , which also results in shutting down the reproductive system to reduce the weight of reproductive organs and facilitate flight. The trigger of cessation of lay in wild species is surely not molt; clutch size is regulated by other factors that vary considerably among species (Klasing, 1998) . It would seem reasonable that one possible trigger, perhaps in concert with or in addition to changes in photoperiod, could be a Ca set point in bone or blood that initiates the release of vasoactive intestinal polypeptide (VIP), which then triggers the release of prolactin to shut down reproductive activity (Hall et al., 1985; Dawson and Sharp, 1998) and protect the skeleton from excessive Ca depletion. In many wild avian seasonally breeding species, termination of reproduction is initiated by the development of photorefractoriness and gonadal regression, followed by a molt (Sharp et al., 1979; Proudman and Opel, 1981; Dawson and Sharp, 1998) . This is quite different from inducing a molt as the means in the laying hen by which reproduction is turned off. In the European starling, prolactin is at its maximum during the postnuptial molt (Dawson and Sharp, 1998) . The commercial laying hen does not exhibit spontaneous broodiness, in contrast to bantam hens, broiler breeder hens, turkey hens, or feral domestic fowl (Johnson, 1986) . Prolactin is high in birds that exhibit broodiness and incubation behaviors (Sharp et al., 1988; Youngren et al., 1991; El-Halawani and Rozenboim, 1993 ) but is not a major hormone in the commercial chicken. In 1962, Bell and Siller suggested that selection in commercial layers had resulted in the loss of a regulatory mechanism by which endogenous Ca might trigger cessation of lay. If this factor happened to be a Casensing mechanism, and with the very substantial amounts of dietary Ca continually available to the laying hen, it may not be possible to answer the question definitively concerning avian osteoporosis and estrogen. However, from a mechanistic perspective, it is also difficult to imagine that a steroid hormone, particularly, would have such fundamentally different actions on similar tissues in 2 classes of vertebrates that in one class a decrease would cause osteoporosis and in another an increase would have the same effect.
